SNGX CIK: 812796

Soligenix Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.10
FY22:
0.40
FY23:
0.10
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.1
FY22:
−14.2
FY23:
−7.70
FY24:
−9.44
FY25:
−11.8
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−11.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.4
FY22:
−15.0
FY23:
−7.91
FY24:
−8.68
FY25:
−11.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.6
FY22:
−13.8
FY23:
−6.14
FY24:
−8.27
FY25:
−11.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data